Gut–lung axis in allergic rhinitis: microbial dysbiosis and therapeutic strategies
Frontiers in Microbiology · 12.12.2025 · 16
DOI: 10.3389/fmicb.2025.1654997 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.12.2025. Verfasst von WeiKeng Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, …. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Longgang District Science and Technology Innovation Bureau, Longgang District Maternity and Child Healthcare Hospital in Shenzhen City.
Abstract (Originalsprache)
Background
Allergic rhinitis (AR) affects an estimated 10%–30% of people worldwide and places a significant burden on both health and healthcare systems. Recent research suggests that imbalances in the gut microbiota may contribute to the development of AR by disrupting immune regulation along the gut–lung axis. However, these insights have yet to be fully translated into clinical practice.
Methods
We performed a systematic review of studies published between 2010 and 2025, including clinical research, animal experiments, and multi-omics analyses, retrieved from PubMed, Web of Science, Embase, Cochrane, CNKI, and Wanfang databases. The review aimed to evaluate immune mechanisms mediated by the gut microbiota and assess microbiota-targeted interventions in AR.
Results
Patients with AR consistently show reduced fecal butyrate levels, with several studies reporting significant declines, alongside elevated serum IgE concentrations. These changes are closely linked to gut dysbiosis, characterized by reduced abundance of Faecalibacterium and imbalances in the Bacteroidetes/Firmicutes ratio. Dysbiosis appears to drive activation of the aryl hydrocarbon receptor (AhR) pathway, evidenced by a 1.5-fold increase in the kynurenine/tryptophan ratio ( p < 0.05), and contributes to impaired regulatory T-cell function. Experimental evidence supports these associations: in murine models, fecal microbiota transplantation (FMT) reduced nasal IL-13 levels by as much as 60% in one study. In human trials, probiotic supplementation, particularly with Clostridium butyricum , was linked to reductions in serum IgE in some cohorts. Integration of multi-omics datasets further reveals conserved mechanisms, including butyrate-mediated histone deacetylase inhibition and vagus nerve–dependent suppression of mast cell activity. Moreover, combinatorial approaches, such as combining probiotics with FXR agonists, have yielded significant improvements in preclinical models, notably reducing nasal symptom scores.
Conclusion
Gut dysbiosis contributes to the development of AR by disrupting immune–metabolic pathways along the gut–lung axis. Microbiota-targeted interventions hold promise for both the prevention and management of AR, especially in pediatric populations. To achieve long-term impact, public health strategies that combine dietary modifications with measures to reduce air pollution are urgently needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong, China.
- Child Healthcare Department, Maternal and Child Health Hospital of PanYu District (Hexian Memorial Hospital of PanYu District), Guangzhou, China.
- Department of Pediatrics, Longgang District Maternity and Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of Shantou University Medical College), Medical Research Institute of Maternal…
Förderung
- Longgang District Science and Technology Innovation Bureau
- Longgang District Maternity and Child Healthcare Hospital in Shenzhen City
Zitieren
APA
Yang, W., Wu, H., Li, X., Wan, Z., Kong, W., & Huang, C. (2025). Gut–lung axis in allergic rhinitis: microbial dysbiosis and therapeutic strategies. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1654997
Vancouver
Yang W, Wu H, Li X, Wan Z, Kong W, Huang C. Gut–lung axis in allergic rhinitis: microbial dysbiosis and therapeutic strategies. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1654997
BibTeX
@article{Yang2025,
author = {Yang, WeiKeng and Wu, Hui and Li, Xiuyun and Wan, Zhi and Kong, Wei and Huang, Congfu},
title = {Gut–lung axis in allergic rhinitis: microbial dysbiosis and therapeutic strategies},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1654997}
}
EUVIMED